Scienture Holdings, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
SCNX$3.20+2.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 6. EXHIBITS
| Exhibit No. | Description |
| 3.1 | Second Amended and Restated Certificate of Incorporation of the Company, as amended through September 20, 2024 (incorporated by reference to Exhibit 3.1 of the Company’s Form 10-K filed on March 26, 2025). |
| 3.2 | Certificate of Amendment to Second Amended and Restated Certificate of Incorporation (1-for-6 Reverse Stock Split of Common Stock) filed with the Delaware Secretary of State on February 12, 2020, and effective February 13, 2020 (incorporated by reference to Exhibit 3.3 of the Company’s Form 10-K filed on March 26, 2025). |
| 3.3 | Certificate of Amendment of Certificate of Incorporation (changing name TRxADE HEALTH, INC.) (incorporated by reference to Exhibit 3.4 of the Company’s Form 10-K filed on March 26, 2025). |
| 3.4 | Form of Certificate of Amendment to Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.5 of the Company’s Form 10-K filed on March 26, 2025). |
| 3.5 | Certificate of Amendment of Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.6 of the Company’s Form 10-K filed on March 26, 2025). |
| 3.6 | Amended and Restated Bylaws of the Company, as amended through October 1, 2025. |
| 10.1 | First Amendment to Employment Agreement effective October 1, 2024, by and between Scienture, LLC and Dr. Narasimhan Mani (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on October 24, 2025). |
| 10.2 | First Amendment to Employment Agreement effective October 1, 2024, by and between Scienture, LLC and Dr. Shankar Hariharan (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed on October 24, 2025). |
| 10.3 | Second Amendment of Loan and Security Agreement dated October 10, 2025, by and among the Company, Scienture, LLC, and NVK Finance, LLC (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on October 16, 2025). |
| 10.4 | Note Purchase Agreement dated October 14, 2025, by and between the Company and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed on October 16, 2025). |
| 10.5 | Secured Promissory Note dated October 14, 2025, made by the Company in favor of Streeterville Capital, LLC (incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K filed on October 16, 2025). |
| 10.6 | Security Agreement dated October 14, 2025, by and between the Company and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.4 of the Company’s Form 8-K filed on October 16, 2025). |
| 10.7 | Security Agreement dated October 14, 2025, by and between Scienture, LLC and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.5 of the Company’s Form 8-K filed on October 16, 2025). |
| 10.8 | Guaranty dated October 14, 2025, made by Scienture, LLC for the benefit of Streeterville Capital, LLC (incorporated by reference to Exhibit 10.6 of the Company’s Form 8-K filed on October 16, 2025). |
| 10.9 | Letter Agreement dated October 2, 2025, by and among the Company, Arena Finance Markets, LP, and Arena Special Opportunities III LP (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on October 3, 2025). |
| 10.10 | Equity Distribution Agreement, dated September 19, 2025, with Maxim Group LLC (incorporated by reference to Exhibit 1.1 of the Company’s Form 8-K filed on September 23, 2025). |
| 10.11 | Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on August 15, 2025). |
| 10.12 | Form of Placement Agency Agreement (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed on August 15, 2025). |
| 10.13# | Form of Common Stock Purchase Agreement by and between Scienture Holdings, Inc. and the investors named therein (incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q filed on August 12, 2025). |
| 31.1 | Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 31.2 | Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 32.1 | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 32.2 | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
Exhibits and/or schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish supplementally copies of any of the omitted exhibits and schedules upon request by the SEC; provided, however, that the registrant may request confidential treatment pursuant to Rule 24b-2 under the Exchange Act for any exhibits or schedules so furnished.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| SCIENTURE HOLDINGS, INC. | |
| By: | /s/ Dr. Narasimhan Mani |
| Dr. Narasimhan Mani | |
| Co-Chief Executive Officer and President (Principal Executive Officer) | |
| By: | /s/ Dr. Shankar Hariharan |
| Dr. Shankar Hariharan | |
| Co-Chief Executive Officer and Executive Chairman (Principal Executive Officer) | |
| By: | /s/ Eric Sherb |
| Eric Sherb | |
| Chief Financial Officer (Principal Accounting/Financial Officer) |
| Date: | November 12, 2025 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.